8:11 AM ET
8-K
Executive Compensation
Processa Pharmaceuticals Executive Compensation
Processa Pharmaceuticals appointed Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026. Mr. Flesher will receive an annual base salary of $700,000, a target bonus of up to 60%, and an initial stock option grant representing 3.0% of the company's fully-diluted capital stock, contingent on shareholder approval of a new equity incentive plan.